Clinical Indication

Autoimmune neurological disorders


Please see shared care agreement for individual indications

Date of classification

June 2021


Shared Care Agreement. Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.